Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
2.86M
-
Shares change
-
+245K
-
Total reported value, excl. options
-
$4.52M
-
Value change
-
+$579K
-
Put/Call ratio
-
0.03
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$1.58
Significant Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q4 2023
25 filings reported holding NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share as of Q4 2023.
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.86M shares
of 50M outstanding shares and own 5.72% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.21M shares), VANGUARD GROUP INC (918K shares), GEODE CAPITAL MANAGEMENT, LLC (197K shares), Mayo Clinic (182K shares), PERKINS CAPITAL MANAGEMENT INC (150K shares), STATE STREET CORP (51.6K shares), MAI Capital Management (50K shares), NORTHERN TRUST CORP (30.3K shares), Wealth Alliance Advisory Group, LLC (19.5K shares), and Virtu Financial LLC (18.1K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.